Acinar cell carcinoma of pancreas

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:424046C25.7C25.8C25.0
Who is this for?
Show terms as
8Active trials35Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Acinar cell carcinoma of the pancreas (ACC) is a rare type of pancreatic cancer that starts in the acinar cells — the cells that normally make digestive enzymes in the pancreas. It is sometimes called pancreatic acinar cell carcinoma or ACC of the pancreas. Unlike the more common type of pancreatic cancer (called pancreatic ductal adenocarcinoma), ACC has some different features and may respond differently to treatment. The pancreas sits behind the stomach and has two main jobs: making digestive juices (enzymes) and controlling blood sugar with hormones like insulin. When acinar cells become cancerous, they can form a tumor that grows and may spread to nearby organs, lymph nodes, or distant parts of the body like the liver. In some cases, the tumor releases too many digestive enzymes into the bloodstream, causing a unique set of symptoms including joint pain, skin rashes, and fatty tissue breakdown under the skin — a condition sometimes called lipase hypersecretion syndrome. Common symptoms include belly pain, unexplained weight loss, nausea, and sometimes a lump in the abdomen. Treatment usually involves surgery when the tumor can be removed, along with chemotherapy and sometimes radiation. Because ACC is rare, treatment is often guided by cancer centers with experience in rare pancreatic tumors. Compared to the most common pancreatic cancer, ACC may have a somewhat better outlook, especially when caught early.

Also known as:

Key symptoms:

Abdominal or belly pain, often in the upper or middle abdomenUnexplained weight lossNausea and vomitingLoss of appetiteA lump or mass felt in the abdomenFatigue and general weaknessJaundice (yellowing of the skin or eyes) if the tumor blocks the bile ductJoint pain or aching, especially in multiple jointsSkin nodules or tender red bumps under the skin (from fat breakdown)Diarrhea or changes in bowel habitsBack painFever in some cases

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

8 events
Aug 2024The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer

Alliance for Clinical Trials in Oncology — PHASE2, PHASE3

TrialACTIVE NOT RECRUITING
Jun 2021APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

National Cancer Institute (NCI) — PHASE2

TrialRECRUITING
Jan 2021A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Artios Pharma Ltd — PHASE1, PHASE2

TrialRECRUITING
Jan 2021SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

General Oncology, Inc. — PHASE1

TrialRECRUITING
Jan 2017Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

National Cancer Institute (NCI) — PHASE2

TrialACTIVE NOT RECRUITING
Apr 2016High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University — NA

TrialRECRUITING
Feb 2010Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery

National Cancer Institute (NCI) — PHASE1

TrialACTIVE NOT RECRUITING
Mar 2009GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery

National Cancer Institute (NCI) — PHASE1

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Acinar cell carcinoma of pancreas.

8 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

8 recruitingView all trials with filters →
Phase 22 trials
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Phase 2
Actively Recruiting
PI: Kim A Reiss Binder (ECOG-ACRIN Cancer Research Group) · Sites: Anchorage, Alaska; Anchorage, Alaska +452 more · Age: 1899 yrs
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Phase 2
Active Prior treatment eligible
PI: Sandip P Patel (SWOG Cancer Research Network) · Sites: Birmingham, Alabama; Mobile, Alabama +18 more · Age: 1899 yrs
Phase 13 trials
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
Phase 1
Actively Recruiting
PI: Arnold Glazier, M.D. (General Oncology, Inc.) · Sites: Boston, Massachusetts; New York, New York · Age: 1899 yrs
Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery
Phase 1
Active
PI: Elizabeth A Poplin (Rutgers Cancer Institute of New Jersey) · Sites: New Brunswick, New Jersey · Age: 1899 yrs
GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery
Phase 1
Active
PI: Charles Erlichman (Mayo Clinic) · Sites: Scottsdale, Arizona; Jacksonville, Florida +2 more · Age: 1899 yrs
N/A1 trial
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
N/A
Actively Recruiting
PI: Harish Lavu, MD (Thomas Jefferson University) · Sites: Cleveland, Ohio; Philadelphia, Pennsylvania · Age: 1899 yrs

Specialists

Showing 25 of 35View all specialists →
KB
Kim A Reiss Binder
Specialist
PI on 1 active trial3 Acinar cell carcinoma of pancreas publications
DM
David Goldstein, MD
Specialist
PI on 1 active trial
RP
R. Padbury
Specialist
PI on 1 active trial
AM
Arnold Glazier, M.D.
NEWTON CENTER, MA
Specialist
PI on 1 active trial
CE
Charles Erlichman
ROCHESTER, MN
Specialist
PI on 2 active trials
AN
Anne Noonan
BOULDER, CO
Specialist
PI on 1 active trial2 Acinar cell carcinoma of pancreas publications
CM
Charles Erlichman, M.D.
ROCHESTER, MN
Specialist
PI on 1 active trial
SA
Simin Ahmadvand
Specialist
1 Acinar cell carcinoma of pancreas publication
AG
Abbas Ghaderi
Specialist
1 Acinar cell carcinoma of pancreas publication
SB
Sima Balouchi-Anaraki
Specialist
1 Acinar cell carcinoma of pancreas publication
AS
Akbar Safaei
Specialist
1 Acinar cell carcinoma of pancreas publication
HK
Hedy Kindler
CHICAGO, IL
Specialist
PI on 7 active trials6 Acinar cell carcinoma of pancreas publications
SP
Sandip P Patel
Birmingham, Alabama
Specialist

Rare Disease Specialist

PI on 1 active trial
EP
Elizabeth A Poplin
CHARLOTTE, NC
Specialist
PI on 1 active trial
KM
Kim Reiss Binder, MD
Specialist
PI on 1 active trial
SM
Susanna Ulahannan, MD
PONCA CITY, OK
Specialist
PI on 1 active trial
AK
Andreas Kaubisch
BRONX, NY
Specialist
PI on 2 active trials
RF
Richard Finn
Specialist
PI on 1 active trial8 Acinar cell carcinoma of pancreas publications
DM
David Bajor, MD
CLEVELAND, OH
Specialist
PI on 2 active trials
EO
Eileen O'Reilly
NEW YORK, NY
Specialist
PI on 1 active trial2 Acinar cell carcinoma of pancreas publications
JM
Jill Lacy, MD
NEW HAVEN, CT
Specialist
PI on 1 active trial
KH
Kyle Holen
MADISON, WI
Specialist
PI on 1 active trial4 Acinar cell carcinoma of pancreas publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources

OPDIVO

E.R. Squibb & Sons, L.L.C.

OPDIVO — Contact E.R. Squibb & Sons, L.L.C.

Unverified — confirm before calling
Patient Assistance
Manufacturer Program
Accepting applications

Travel Grants

No travel grants are currently matched to Acinar cell carcinoma of pancreas.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Acinar cell carcinoma of pancreasForum →

No community posts yet. Be the first to share your experience with Acinar cell carcinoma of pancreas.

Start the conversation →

Latest news about Acinar cell carcinoma of pancreas

1 articles
Clinical trialCLINICALTRIALSMar 26, 2026
New Clinical Trial: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013)
Researchers are testing two cancer-fighting drugs called nivolumab and ipilimumab together to treat patients with rare types of cancer. These drugs help the bod
See all news about Acinar cell carcinoma of pancreas

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Has my tumor been tested for specific genetic changes, and could those changes make me eligible for targeted therapy or a clinical trial?,Is my tumor able to be removed with surgery, and what are the risks and benefits of that operation?,What chemotherapy regimen do you recommend for my situation, and what side effects should I expect?,Should I get germline (inherited) genetic testing to see if a hereditary cancer syndrome runs in my family?,Are there any clinical trials I should consider given how rare this cancer is?,Will I need pancreatic enzyme supplements or diabetes management after treatment?,How often will I need follow-up scans, and what are the signs that the cancer may be coming back?

Common questions about Acinar cell carcinoma of pancreas

What is Acinar cell carcinoma of pancreas?

Acinar cell carcinoma of the pancreas (ACC) is a rare type of pancreatic cancer that starts in the acinar cells — the cells that normally make digestive enzymes in the pancreas. It is sometimes called pancreatic acinar cell carcinoma or ACC of the pancreas. Unlike the more common type of pancreatic cancer (called pancreatic ductal adenocarcinoma), ACC has some different features and may respond differently to treatment. The pancreas sits behind the stomach and has two main jobs: making digestive juices (enzymes) and controlling blood sugar with hormones like insulin. When acinar cells become

How is Acinar cell carcinoma of pancreas inherited?

Acinar cell carcinoma of pancreas follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Acinar cell carcinoma of pancreas typically begin?

Typical onset of Acinar cell carcinoma of pancreas is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Acinar cell carcinoma of pancreas?

Yes — 8 recruiting clinical trials are currently listed for Acinar cell carcinoma of pancreas on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Acinar cell carcinoma of pancreas?

25 specialists and care centers treating Acinar cell carcinoma of pancreas are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Acinar cell carcinoma of pancreas?

1 patient support program are currently tracked on UniteRare for Acinar cell carcinoma of pancreas. See the treatments and support programs sections for copay assistance, eligibility, and contact details.